Shed is a legitimate telehealth platform offering compounded GLP-1 medications, including tirzepatide. This review covers Shed's typical pricing structure, what's commonly included versus billed separately, and how it compares to Luma Health. Shed and Luma Health are completely separate, unaffiliated companies.
Shed's specific pricing tiers and fee structure can change, and not every provider publishes complete pricing transparently. The figures below reflect typical market-rate pricing reported for Shed's tirzepatide program as of mid-2026. Always confirm current pricing directly on Shed's website before signing up — and ask explicitly about consultation fees, shipping costs, and how pricing changes as your dose increases, since these are the components most commonly left out of advertised "starting from" prices industry-wide.
What "Hidden Costs" Usually Means in GLP-1 Telehealth
When patients search for "hidden costs" associated with any GLP-1 provider, they're typically trying to answer a few specific questions: Does the advertised price match what I'll actually be billed each month? Does the cost change as my dose increases during titration? Are there separate consultation, membership, or shipping fees not included in the headline number? What happens to pricing after an introductory period ends?
These are the right questions to ask about any provider — including Luma Health. The honest answer for Shed, based on typical patterns reported across the compounded GLP-1 telehealth space, is that providers using a tiered or dose-dependent pricing model often see total costs rise as patients reach therapeutic and maintenance doses, even when the entry-level price looked competitive.
Shed's Typical Tirzepatide Pricing Structure
Shed's publicly reported pricing for compounded tirzepatide has historically fallen in the $250–$450/month range, varying by dose tier and plan length. This is consistent with typical compounded tirzepatide pricing reported across the broader telehealth market for providers using dose-based pricing models, where the per-month cost increases as your prescribed dose increases through titration (2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg).
Comparing to Luma Health's all-inclusive flat pricing:
- Tirzepatide: Shed ~$250–$450/mo (dose-dependent) vs. Luma Health $165/mo flat regardless of dose — potentially $1,020–$3,420/year more at Shed depending on which dose tier you reach
- Semaglutide: Shed pricing for semaglutide commonly starts lower but follows the same dose-tiered structure as patients titrate up
Both providers use the same general class of active ingredients (compounded semaglutide and tirzepatide) sourced through licensed compounding pharmacies. The cost difference comes from pricing architecture — dose-tiered vs. flat — not from any difference in the medication itself.
💡 The dose-tier trap: A provider that looks affordable at the 2.5mg starting dose can become significantly more expensive once you reach a therapeutic 10mg–15mg maintenance dose, which is where most patients land after several months of titration. Always ask any provider — Shed, Luma Health, or otherwise — what your specific cost will be at your expected maintenance dose, not just the starting price.
What to Verify Before Signing Up with Any Provider
Questions worth asking before enrolling
Shed vs Luma Health: At a Glance
| Factor | Shed (typical reported pricing) | Luma Health |
|---|---|---|
| Tirzepatide pricing model | Dose-tiered, ~$250–$450/mo | Flat $165/mo, any dose |
| Cost at starting dose (2.5mg) | Lower tier pricing | $165/mo (same as all doses) |
| Cost at maintenance dose (10–15mg) | Higher tier pricing | $165/mo (unchanged) |
| Pharmacy partner disclosed publicly | Varies — verify directly | Yes — VialsRX, licensed 503A pharmacy |
| Clinical provider | Shed's own clinical network | Wasef Health, PC |
| Cancellation | Verify current policy directly | Month-to-month, no contract |
Luma Health at $165/month is all-inclusive — medication, clinical consultation through Wasef Health, PC, dose adjustments throughout titration, refills, and free shipping. No membership fees, no dose-tier increases, no hidden charges as you progress through treatment.
Who Shed Might Be Right For
Every provider has a patient profile where it makes sense. Shed may be the right choice if you've had a positive experience with the platform specifically, if the lower-tier starting price fits your budget for the early phase of treatment, or if specific program features Shed offers align with what you're looking for. Cost is one factor among several — your personal fit with a provider's intake process, communication style, and support model matters too.
Who Luma Health Is Right For
Luma Health is the stronger choice for patients who want: predictable, flat-rate pricing that doesn't increase as their dose titrates upward; transparent pharmacy disclosure (VialsRX is publicly named); a GLP-1 specialist clinical focus rather than a broader platform; and month-to-month flexibility with no long-term contract risk.
Clinical Evidence on Tirzepatide
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity" (SURMOUNT-1). NEJM. 2022;387:205–216. Tirzepatide 15mg produced approximately 22.5% mean body weight reduction at 72 weeks in adults with obesity without diabetes; 5mg and 10mg doses produced 16.0% and 21.4% reductions respectively.
- Frías JP, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes" (SURPASS-2). NEJM. 2021. In a 40-week head-to-head trial, tirzepatide 15mg produced approximately 11.2kg of body-weight reduction vs. 5.7kg on semaglutide 1mg.
- Malhotra A, et al. "Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity" (SURMOUNT-OSA). NEJM. 2024. Tirzepatide reduced the apnea-hypopnea index by approximately 27–30 events/hour at 52 weeks vs. roughly 5 events/hour reduction on placebo.
Frequently Asked Questions
Shed is a legitimate telehealth platform offering compounded GLP-1 medications through licensed clinicians and compounding pharmacies. The comparison to Luma Health is about pricing structure and transparency, not legitimacy — both are real medical services.
If Shed uses a dose-tiered pricing model (where cost increases as your prescribed dose increases), the total cost over a typical 6–12 month titration to a therapeutic maintenance dose can exceed what a flat-rate provider like Luma Health charges, even if Shed's entry-level starting price looked lower. Always compare the cost at your expected maintenance dose, not just the starting tier.
Pricing changes over time across the industry. Visit Shed's website directly and ask their support team specifically what the total monthly cost will be at your highest expected dose, whether any membership or consultation fees apply, and whether shipping is included — this gives you the real all-in number to compare against alternatives.
Yes. Start Luma Health's intake first (about 5–10 minutes online), get your prescription approved, and confirm VialsRX is shipping before discontinuing Shed. Request your medical records from Shed (current dose, titration history) so Luma Health's clinical team can continue treatment at your established dose without restarting.
Yes. Luma Health charges $165/month flat for compounded tirzepatide regardless of your prescribed dose — whether you're starting at 2.5mg or have titrated up to the maximum 15mg maintenance dose. This is a deliberate design choice to make cost predictable throughout your entire treatment course.